Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis.
about
Utility of blood procalcitonin concentration in the management of cancer patients with infectionsProspective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.The utility of initial procalcitonin and procalcitonin clearance for prediction of bacterial infection and outcome in critically ill patients with autoimmune diseases: a prospective observational study.Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritisHemorrhagic Pericardial Effusion with Tamponade: A Rare Adverse Effect of Infliximab-Case Report and Literature Review.Procalcitonin, and cytokines document a dynamic inflammatory state in non-infected cirrhotic patients with ascites.Distinguishing infections vs flares in patients with systemic lupus erythematosus.Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.Procalcitonin for prediction of chorioamnionitis in preterm premature rupture of membranes.Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.Biomarkers in sepsis.Differentiating Clostridium difficile Colitis from Clostridium difficile Colonization in Ulcerative Colitis: A Role for Procalcitonin.A meta-analysis to assess usefulness of procalcitonin-guided antibiotic usage for decision making.
P2860
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
P2860
Use of serum procalcitonin to detect bacterial infection in patients with autoimmune diseases: a systematic review and meta-analysis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Use of serum procalcitonin to ...... atic review and meta-analysis.
@ast
Use of serum procalcitonin to ...... atic review and meta-analysis.
@en
Use of serum procalcitonin to ...... atic review and meta-analysis.
@nl
type
label
Use of serum procalcitonin to ...... atic review and meta-analysis.
@ast
Use of serum procalcitonin to ...... atic review and meta-analysis.
@en
Use of serum procalcitonin to ...... atic review and meta-analysis.
@nl
prefLabel
Use of serum procalcitonin to ...... atic review and meta-analysis.
@ast
Use of serum procalcitonin to ...... atic review and meta-analysis.
@en
Use of serum procalcitonin to ...... atic review and meta-analysis.
@nl
P2093
P2860
P356
P1476
Use of serum procalcitonin to ...... atic review and meta-analysis.
@en
P2093
Chien-Chang Lee
Chih-Jung Shen
Hsiang-Yun Cheng
Jiunn-Yih Wu
Ping-Hsiung Yo
Rai-Chi Chan
Shy-Shin Chang
Si-Huei Lee
Yueh-Che Hsieh
P2860
P304
P356
10.1002/ART.34512
P577
2012-09-01T00:00:00Z